Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558232 · ClinicalTrials.gov registry record · NA
A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients
A NA study, sponsored by Tibion Bionics.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01558232: Clinical Trial NA study, sponsored by Tibion Bionics.
NCT01558232 is a NA study that was terminated before completion, run by Tibion Bionics. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558232, a NA study, was terminated before completion, sponsored by Tibion Bionics.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this clinical study is to examine acute changes in stability, force allocation, work, and mobility from using a wearable, portable, battery-operated robotic orthosis (the Tibion Bionic Leg) in subacute post-stroke persons undergoing lower extremity physical therapy.
Interventions
- DEVICE Tibion Bionic Leg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01558232
The ClinicalTrials.gov registry entry for NCT01558232 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tibion Bionics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tibion Bionic Leg is the first listed.
NCT01558232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01558232 about?
NCT01558232 is a clinical study titled "A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients". The objective of this clinical study is to examine acute changes in stability, force allocation, work, and mobility from using a wearable, portable, battery-operated robotic orthosis (the Tibion Bionic Leg) in subacute post-stroke persons undergoing lower extremity physical therapy.
What is the current status of trial NCT01558232?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2012-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01558232?
The interventions under investigation include: Tibion Bionic Leg (DEVICE).
Who is sponsoring clinical trial NCT01558232?
This trial is sponsored by Tibion Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.